Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 27 | 2020 | 3450 | 1.900 |
Why?
|
| Contrast Media | 15 | 2020 | 986 | 1.480 |
Why?
|
| Carcinogenesis | 3 | 2020 | 235 | 1.020 |
Why?
|
| Vanadates | 8 | 2009 | 32 | 0.990 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 191 | 0.950 |
Why?
|
| Vanadium | 3 | 2015 | 13 | 0.850 |
Why?
|
| Gadolinium DTPA | 7 | 2017 | 233 | 0.800 |
Why?
|
| Electron Spin Resonance Spectroscopy | 15 | 2005 | 324 | 0.780 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2020 | 58 | 0.770 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 135 | 0.720 |
Why?
|
| beta-Lactamases | 5 | 2004 | 57 | 0.610 |
Why?
|
| Arteries | 1 | 2020 | 170 | 0.600 |
Why?
|
| Spin Labels | 8 | 2013 | 105 | 0.590 |
Why?
|
| Mammary Glands, Animal | 5 | 2020 | 81 | 0.550 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 267 | 0.540 |
Why?
|
| Calcium Oxalate | 2 | 2015 | 188 | 0.530 |
Why?
|
| Feeding Behavior | 1 | 2020 | 337 | 0.530 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 129 | 0.520 |
Why?
|
| Microscopy, Fluorescence | 3 | 2015 | 435 | 0.510 |
Why?
|
| Dietary Fats | 1 | 2017 | 134 | 0.490 |
Why?
|
| Durapatite | 1 | 2015 | 36 | 0.460 |
Why?
|
| Prostate | 2 | 2017 | 416 | 0.460 |
Why?
|
| Poloxamer | 3 | 2017 | 24 | 0.450 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 2479 | 0.440 |
Why?
|
| Electron Probe Microanalysis | 1 | 2015 | 8 | 0.440 |
Why?
|
| Animals | 33 | 2020 | 27973 | 0.400 |
Why?
|
| Mice | 17 | 2020 | 12230 | 0.390 |
Why?
|
| Surface-Active Agents | 2 | 2017 | 57 | 0.380 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 479 | 0.380 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 81 | 0.370 |
Why?
|
| Glycoproteins | 3 | 2000 | 216 | 0.370 |
Why?
|
| Models, Molecular | 9 | 2005 | 1353 | 0.350 |
Why?
|
| Colitis | 2 | 2014 | 260 | 0.340 |
Why?
|
| Organometallic Compounds | 3 | 2013 | 138 | 0.310 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 606 | 0.290 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 570 | 0.260 |
Why?
|
| Tumor Burden | 2 | 2020 | 321 | 0.260 |
Why?
|
| Prostatic Hyperplasia | 2 | 2019 | 95 | 0.250 |
Why?
|
| Escherichia coli | 5 | 2004 | 562 | 0.250 |
Why?
|
| Muramidase | 3 | 2017 | 32 | 0.250 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 578 | 0.250 |
Why?
|
| Binding Sites | 9 | 2004 | 1126 | 0.230 |
Why?
|
| Calcium | 4 | 2002 | 1173 | 0.230 |
Why?
|
| Molecular Structure | 6 | 2007 | 305 | 0.210 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2015 | 121 | 0.210 |
Why?
|
| Protein Conformation | 7 | 2004 | 907 | 0.210 |
Why?
|
| Cations, Divalent | 1 | 2003 | 34 | 0.200 |
Why?
|
| Pyrophosphatases | 1 | 2003 | 16 | 0.200 |
Why?
|
| Gadolinium | 3 | 2015 | 95 | 0.190 |
Why?
|
| Ions | 2 | 2000 | 74 | 0.190 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 399 | 0.190 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1769 | 0.190 |
Why?
|
| Kinetics | 7 | 2004 | 1463 | 0.180 |
Why?
|
| Rats | 8 | 2013 | 4028 | 0.180 |
Why?
|
| Methyl Methanesulfonate | 1 | 2002 | 4 | 0.180 |
Why?
|
| Carboxypeptidases | 2 | 1994 | 34 | 0.180 |
Why?
|
| Neoplasms | 4 | 2020 | 3168 | 0.170 |
Why?
|
| Female | 14 | 2020 | 48547 | 0.170 |
Why?
|
| Polyethylene Glycols | 2 | 2017 | 371 | 0.160 |
Why?
|
| Cyclic N-Oxides | 3 | 1993 | 32 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2001 | 135 | 0.160 |
Why?
|
| Cattle | 4 | 2007 | 392 | 0.160 |
Why?
|
| Water | 4 | 2008 | 306 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 183 | 0.160 |
Why?
|
| Organ Size | 1 | 2020 | 360 | 0.150 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 2757 | 0.140 |
Why?
|
| Dietary Sugars | 1 | 2018 | 8 | 0.140 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 11 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3431 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1581 | 0.130 |
Why?
|
| Diet, Fat-Restricted | 1 | 2018 | 30 | 0.130 |
Why?
|
| Injections, Intravenous | 2 | 2015 | 212 | 0.130 |
Why?
|
| Ligands | 3 | 2016 | 476 | 0.130 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2017 | 25 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2011 | 626 | 0.130 |
Why?
|
| Weaning | 1 | 2017 | 26 | 0.130 |
Why?
|
| Catalysis | 5 | 2003 | 215 | 0.130 |
Why?
|
| Ethylenediamines | 1 | 2017 | 14 | 0.130 |
Why?
|
| Protein Unfolding | 1 | 2017 | 12 | 0.130 |
Why?
|
| Adiposity | 1 | 2017 | 75 | 0.130 |
Why?
|
| Protein Aggregates | 1 | 2017 | 28 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2018 | 144 | 0.130 |
Why?
|
| ADAM17 Protein | 1 | 2016 | 9 | 0.120 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 16 | 0.120 |
Why?
|
| Protein Denaturation | 2 | 2007 | 109 | 0.120 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 49 | 0.120 |
Why?
|
| Simian virus 40 | 1 | 2015 | 35 | 0.110 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2015 | 48 | 0.110 |
Why?
|
| Carboxypeptidases A | 3 | 2007 | 11 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 473 | 0.110 |
Why?
|
| ErbB Receptors | 2 | 2016 | 504 | 0.110 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 53 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2014 | 1269 | 0.110 |
Why?
|
| Image Enhancement | 3 | 2020 | 498 | 0.110 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 32 | 0.110 |
Why?
|
| Epithelium | 1 | 2015 | 314 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 280 | 0.100 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 83 | 0.100 |
Why?
|
| Artifacts | 1 | 2015 | 241 | 0.100 |
Why?
|
| Glycolysis | 1 | 2015 | 186 | 0.100 |
Why?
|
| Diffusion | 1 | 2013 | 94 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 130 | 0.100 |
Why?
|
| Radiography | 1 | 2015 | 750 | 0.100 |
Why?
|
| Circular Dichroism | 3 | 2000 | 117 | 0.100 |
Why?
|
| Acylation | 3 | 2004 | 68 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 3 | 2012 | 353 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 165 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1236 | 0.100 |
Why?
|
| Penicillanic Acid | 2 | 2004 | 12 | 0.090 |
Why?
|
| Freezing | 2 | 2004 | 30 | 0.090 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 63 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 347 | 0.090 |
Why?
|
| Solutions | 3 | 2005 | 83 | 0.090 |
Why?
|
| Hydrolysis | 2 | 2004 | 140 | 0.090 |
Why?
|
| Niacinamide | 1 | 2012 | 101 | 0.090 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 97 | 0.090 |
Why?
|
| Microvessels | 2 | 2009 | 68 | 0.090 |
Why?
|
| Male | 8 | 2019 | 44360 | 0.090 |
Why?
|
| Solvents | 2 | 2002 | 91 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2011 | 823 | 0.080 |
Why?
|
| Deuterium | 2 | 2001 | 34 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2011 | 91 | 0.080 |
Why?
|
| Molecular Conformation | 3 | 2005 | 111 | 0.080 |
Why?
|
| Intestines | 1 | 2013 | 433 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 102 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 278 | 0.080 |
Why?
|
| Camellia sinensis | 1 | 2009 | 6 | 0.080 |
Why?
|
| Angiogenesis Modulating Agents | 1 | 2009 | 4 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2010 | 336 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2009 | 124 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2017 | 337 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 603 | 0.070 |
Why?
|
| Humans | 12 | 2019 | 93138 | 0.070 |
Why?
|
| Protons | 3 | 2008 | 100 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 1910 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 47 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 810 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2009 | 247 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 101 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 109 | 0.060 |
Why?
|
| Algorithms | 3 | 2010 | 1948 | 0.060 |
Why?
|
| Progesterone | 1 | 2007 | 114 | 0.060 |
Why?
|
| Drug Design | 1 | 2007 | 133 | 0.060 |
Why?
|
| Protein Binding | 3 | 2002 | 1526 | 0.060 |
Why?
|
| Substrate Specificity | 3 | 2004 | 361 | 0.060 |
Why?
|
| Pregnancy | 1 | 2013 | 3128 | 0.060 |
Why?
|
| Protein Renaturation | 1 | 2005 | 4 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1786 | 0.060 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 60 | 0.060 |
Why?
|
| Injections | 2 | 2017 | 121 | 0.060 |
Why?
|
| Models, Biological | 2 | 2009 | 1768 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2005 | 101 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2005 | 68 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2705 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2004 | 422 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 3155 | 0.050 |
Why?
|
| Buffers | 1 | 2004 | 24 | 0.050 |
Why?
|
| Enterobacter cloacae | 1 | 2004 | 8 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 40 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 1054 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2005 | 520 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 479 | 0.050 |
Why?
|
| Manganese | 1 | 2003 | 55 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 378 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 661 | 0.050 |
Why?
|
| Magnesium | 1 | 2003 | 170 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 647 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2009 | 808 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 119 | 0.050 |
Why?
|
| Chickens | 2 | 2017 | 193 | 0.040 |
Why?
|
| Surface Properties | 1 | 2002 | 126 | 0.040 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2001 | 3 | 0.040 |
Why?
|
| Penicillin G | 1 | 2001 | 4 | 0.040 |
Why?
|
| Asparagine | 1 | 2001 | 27 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 468 | 0.040 |
Why?
|
| Vanadium Compounds | 1 | 2000 | 2 | 0.040 |
Why?
|
| Cysteine | 1 | 2002 | 145 | 0.040 |
Why?
|
| Malonates | 1 | 2000 | 11 | 0.040 |
Why?
|
| Magnetics | 1 | 2000 | 39 | 0.040 |
Why?
|
| Anisotropy | 1 | 2000 | 61 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 268 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 368 | 0.040 |
Why?
|
| beta-Lactams | 1 | 2000 | 15 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2121 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 192 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 501 | 0.040 |
Why?
|
| Nitrogen | 1 | 2000 | 71 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 295 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1994 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 2889 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 494 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 638 | 0.030 |
Why?
|
| Fructose | 1 | 2018 | 36 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 308 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 297 | 0.030 |
Why?
|
| Spiro Compounds | 1 | 2016 | 22 | 0.030 |
Why?
|
| Estradiol | 1 | 2017 | 247 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 49 | 0.030 |
Why?
|
| Metals | 1 | 1996 | 101 | 0.030 |
Why?
|
| Diet, Western | 1 | 2016 | 45 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 944 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2019 | 472 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1093 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 1994 | 726 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 453 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 163 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1519 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 302 | 0.030 |
Why?
|
| Cations | 1 | 1995 | 29 | 0.030 |
Why?
|
| Porphyrins | 1 | 1995 | 36 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 3497 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2014 | 47 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2014 | 93 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 28 | 0.030 |
Why?
|
| Succinates | 1 | 1994 | 25 | 0.030 |
Why?
|
| Amino Acids | 1 | 1995 | 245 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 116 | 0.030 |
Why?
|
| Oxyquinoline | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2013 | 14 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 25 | 0.020 |
Why?
|
| Kidney Calculi | 1 | 1996 | 343 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 38 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2013 | 72 | 0.020 |
Why?
|
| Mammography | 1 | 2017 | 494 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 177 | 0.020 |
Why?
|
| Perfusion | 1 | 2014 | 260 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1993 | 41 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 1993 | 17 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 456 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 526 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2015 | 550 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2019 | 10132 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 47 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 371 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 609 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 298 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 100 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 192 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 653 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 94 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1529 | 0.020 |
Why?
|
| Extremities | 1 | 2011 | 170 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 804 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 603 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2002 | 981 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1304 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 82 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2008 | 102 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1732 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2008 | 48 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2008 | 123 | 0.020 |
Why?
|
| Liver | 1 | 1993 | 1206 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 20398 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 753 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1687 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 913 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 195 | 0.010 |
Why?
|
| Pyrones | 1 | 2005 | 8 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 2005 | 22 | 0.010 |
Why?
|
| 3T3-L1 Cells | 1 | 2005 | 35 | 0.010 |
Why?
|
| Electroporation | 1 | 2005 | 59 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 27539 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 27850 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 131 | 0.010 |
Why?
|
| Glycogen | 1 | 2005 | 57 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 1120 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 584 | 0.010 |
Why?
|
| Adipocytes | 1 | 2005 | 169 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 672 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 379 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Amino Acids, Acidic | 1 | 2002 | 1 | 0.010 |
Why?
|
| Lithostathine | 1 | 2002 | 2 | 0.010 |
Why?
|
| Dialysis | 1 | 2002 | 22 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 136 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 331 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2000 | 9 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 5380 | 0.010 |
Why?
|
| Culture Media | 1 | 2000 | 138 | 0.010 |
Why?
|
| Static Electricity | 1 | 2000 | 94 | 0.010 |
Why?
|
| Tryptophan | 1 | 1994 | 104 | 0.010 |
Why?
|
| Alcohols | 1 | 1993 | 14 | 0.010 |
Why?
|
| Horses | 1 | 1993 | 35 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1994 | 190 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1993 | 61 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 4265 | 0.000 |
Why?
|